GCLC Cancer Research Results
GCLC, Glutamate-Cysteine Ligase, Catalytic Subunit: Click to Expand ⟱
| Source: |
| Type: |
The GCLC gene (Glutamate-Cysteine Ligase, Catalytic Subunit) is a key regulator of glutathione synthesis, and its expression has been studied in various types of cancer.
GCLC gene has been found to be:
Amplified in 15% of breast cancer cases
Mutated in 5% of lung cancer cases
Deleted in 10% of prostate cancer cases
Methylated in 20% of colorectal cancer cases
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Nor, |
MEF |
|
|
|
NRF2↑, selectivity↑, NQO1↑, GCLC↑, HO-1↑, TumCP↓,
*antiOx↑, *Inflam↓, AntiCan↑, *ROS↓, *MDA↓, *GSH↓, *NRF2↑, *GPx↑, *GCLC↑, *GCLM↑,
*antiOx↑, *ROS↓, *GSH↑, *GCLC↑, *GSS↑, *Akt↑, *NRF2↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GCLC↑, 1, HO-1↑, 1, NQO1↑, 1, NRF2↑, 1,
Migration ⓘ
TumCP↓, 1,
Drug Metabolism & Resistance ⓘ
selectivity↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1,
Total Targets: 7
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, GCLC↑, 2, GCLM↑, 1, GPx↑, 1, GSH↓, 1, GSH↑, 1, GSS↑, 1, MDA↓, 1, NRF2↑, 2, ROS↓, 2,
Cell Death ⓘ
Akt↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Total Targets: 12
Scientific Paper Hit Count for: GCLC, Glutamate-Cysteine Ligase, Catalytic Subunit
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:966 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page